Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026

RegulatoryDesogestrel-containing contraceptivesEtonogestrel-containing contraceptivesLitfuloNeutral

AI Analysis

Summary

The European Medicines Agency's PRAC committee reviewed new safety information for desogestrel- and etonogestrel-containing contraceptives and Litfulo (alopecia areata treatment) during its July 6-9, 2026 meeting. The committee agreed to assess these safety signals as part of routine pharmacovigilance activities.

Outcome Details

PRAC agreed on new safety information for desogestrel- and etonogestrel-containing contraceptives and Litfulo

Importance:3/10

Sentiment:

0.00

pharmacovigilancePRACsafety signalcontraceptivesalopecia areataEMA

Related Companies

$SHWZ $TRAX

Read the original article

Published by EMA News on July 10, 2026 10:00 AM

Read Original